Berlin, Germany, and Uppsala, Sweden, October 15, 2015 / B3C newswire / - BioGenes GmbH, a global leader in host cell protein (HCP) assay development, and Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, announce a cooperation for use of BioGenes’ 360-HCP antibodies in Gyrolab™ CHO-HCP Kits 2-5. The four Gyrolab™ CHO-HCP Kits, which have been introduced recently, quantify host cell proteins from Chinese hamster ovary (CHO) cells and are used in biomanufacturing processes.
360-HCP antibodies from BioGenes have been developed according to a novel approach and stand out by their ability to cover the broadest possible spectrum of antigens. 360-HCP antibodies have been generated by immunizing different species combined with an optimized antigen and antibody preparation as well as purification strategy resulting in several antibody preparations. Thus each Gyrolab™ CHO-HCP Kit contains antibody preparations that have been generated in different species using slightly different antigens.
Gyros’ kits are validated for use on the nanoliter-scale microfluidic systems Gyrolab xP workstation and Gyrolab xPlore which are in use in GLP and GMP environments in most of the top biopharma and CROs across the world. Primarily, BioGenes has developed the 360-HCP antibodies for its enhanced generic CHO|360-HCP ELISA. Through the collaboration with Gyros the 360-HCP antibodies can now also be used in in high-throughput analyses.
The new Gyrolab™ CHO-HCP Kits will be showcased at BPI 2015 on 26-29 October in Boston, MA.
About BioGenes
BioGenes GmbH specializes in highly sophisticated and customized antibody and immunoassay development and is an experienced and reliable partner for process development improvements in all areas of quality control, diagnostics and drug discovery. BioGenes is certified to meet the international requirements and regularities of quality assurance and animal welfare. The Company maintains long-term relationships with research institutes, universities and biotech and pharmaceutical companies, including eight of the ten largest pharmaceutical companies in the world. The company has been evaluated by a leading global accounting and auditing firm to be one of the leading companies in HCP assay development.
About Gyros
Gyros manufactures laboratory instruments, consumables, kits and software to maximize laboratory productivity by miniaturizing and automating immunoassays at nanoliter-scale. Gyrolab™ systems use proven microfluidic CD technology to analyze large numbers of samples in parallel, ensuring uniform processing and yielding up to 112 data points in less than one hour. Gyros will put a new spin on what’s possible in your laboratory.
Contact
Dagmar Schwertner-Knoll
Marketing/Sales Director
BioGenes GmbH
+49-30-65762380
This email address is being protected from spambots. You need JavaScript enabled to view it.